(Press-News.org) Indiana University School of Medicine researchers studying clonal hematopoiesis of indeterminate potential (CHIP), a blood condition that may increase the risk of blood cancer, discovered that obesity was strongly associated with the condition. Their findings were recently published in the Journal of Clinical Investigation.
CHIP is a condition where blood cells accumulate genetic mutations, increasing the risk of developing blood cancer. Although CHIP is common in aging, the risk factors that contribute to the condition are poorly understood.
“Our study’s results showed being overweight or obese may be a risk factor for CHIP because obesity causes inflammation in the body and changes the bone marrow where blood cells are made. This increases a person’s risk for blood cancer and cardiovascular disease,” said lead author of the published study Santhosh Pasupuleti, PhD, assistant research professor of pediatrics at the Herman B Wells Center for Pediatric Research and a researcher at the IU Melvin and Bren Simon Comprehensive Cancer Center. “The significance of our findings offers potential new avenues for treatment in individuals with CHIP and obesity.”
The researchers analyzed data from more than 47,000 individuals with CHIP and found 5.8 percent of the population was associated with a significant increase in waist-to-hip ratio. Additionally, mice models with obesity and CHIP used in the study were observed to have mutated blood cells grow more quickly. Thus, their work strongly supports the notion that finding ways to maintain a healthy weight and keeping one’s level of systemic inflammation in check may lower the risk of developing blood cancer with age.
“Our current and future studies are focused on identifying therapeutic strategies to mitigate the expansion and rapid growth of CHIP-bearing mutated blood cells,” said Reuben Kapur, PhD, director of the Herman B Wells Center for Pediatric Research, co-program leader of Hematopoiesis and Hematologic Malignancies at the IU Melvin and Bren Simon Comprehensive Cancer Center, and co-author of the study. “Surprisingly, our initial findings suggest that common medications used for treating blood pressure and diabetes may play a role in regulating the growth of mutated blood cells. Additional future studies will focus on examining individuals who are on these types of medications and their long-term risks of developing blood cancer.”
As part of their study, the investigators also tested different drug combinations to target CHIP mutant cells and find potential therapeutic approaches for the condition. Overall, the research suggests that a better understanding of the relationship between CHIP and obesity may help identify individuals at risk of developing diseases like leukemia and find methods for future treatments.
END
IU researchers find link between obesity and blood cancer
2023-05-16
ELSE PRESS RELEASES FROM THIS DATE:
Degradation of Rhodamine B in the photocatalytic reactor containing TiO2 nanotube arrays coupled with nanobubbles
2023-05-16
The study is led by Xiaojun Han (School of Chemistry and Chemical Engineering, Harbin Institute of Technology).
With the rapid development of urbanization and industrialization, environmental problems became increasingly serious. Dye wastewater is considered to be one of the biggest challenges due to its high toxicity. Organic dyes have mutagenic, teratogenic, and carcinogenic properties, and threaten the health and life of humans while hindering plant photosynthesis, which brings risks to the ecosystem. Traditional organic pollutant treatment ...
Occasional cannabis use during pregnancy may be enough to impact fetal growth significantly
2023-05-16
As more people use cannabis for recreational purposes, attitudes towards the drug have changed. For example, research has shown that dispensaries often recommend cannabis – also referred to as marijuana – to pregnant women to ease pregnancy symptoms, especially morning sickness.
There is a growing body of literature attesting to poor child outcomes if cannabinoids are consumed during pregnancy. The exact effects on the developing fetus, however, remain unclear. Researchers in the US have now examined how timing of cannabis exposure during pregnancy impacts fetal development.
“We show that even when marijuana use occurred only ...
Severe hot flashes after menopause increase metabolic syndrome risk in women
2023-05-16
EMBARGOED UNTIL SUNDAY 14 MAY 2023 AT 00:01 CET
Severe hot flashes after menopause increase metabolic syndrome risk in women
Women who experience more severe hot flashes after menopause are more likely to develop metabolic syndrome and high blood pressure, according to research presented at the 25th European Congress of Endocrinology in Istanbul. The findings of this long-term study highlight the importance of using hormone replacement therapy for menopause in these women.
Metabolic syndrome is a group of three or more ...
Newly discovered RNA molecules hold promise for detecting and treating esophageal cancer
2023-05-15
CLEVELAND—Irregularities in the body’s genetic coding to make proteins are linked to cancerous tumors. But most genetic material contains elements whose function isn’t clear.
Could abnormalities in non-coding material also impact a person’s health, or even be linked to cancers as well?
A new study by researchers at the Case Western Reserve University School of Medicine suggests that the non-coding genetic molecules also play a key role in health and disease, including tumor development.
More specifically, ...
Henry Ford Health cardiologists look to the past to create new heart bypass procedure
2023-05-15
DETROIT (May 15, 2023) – Henry Ford Health Interventional cardiologists William O’Neill, M.D., and Khaldoon Alaswad, M.D., took a page out of the medical history books by performing a new coronary bypass procedure replicated from one not used in decades to treat a patient living with crippling angina ― a severe symptom of coronary artery disease.
Retired painting contractor Fred Casciano, 60, from Traverse City, became the first patient anywhere to receive the life-changing transcatheter procedure on April 12 at Henry Ford Hospital in Detroit. The procedure was re-engineered from an operation first developed in the 1950s.
“This new ...
Novel AI-based software enables quick and reliable imaging of proteins in cells
2023-05-15
The more, the better
“TomoTwin paves the way for automated identification and localization of proteins directly in their cellular environment, expanding the potential of cryo-ET,” says Gavin Rice, co-first author of the publication. Cryo-ET has the potential to decipher how biomolecules work within a cell and, by that, to unveil the basis of life and the origin of diseases.
In a cryo-ET experiment, scientists use a transmission electron microscope to obtain 3D images, called tomograms, of the cellular volume containing complex biomolecules. To gain a more detailed image of ...
Clinical trial of mRNA universal influenza vaccine candidate begins
2023-05-15
A clinical trial of an experimental universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center (VRC), part of the National Institutes of Health, has begun enrolling volunteers at Duke University in Durham, North Carolina. This Phase 1 trial will test the experimental vaccine, known as H1ssF-3928 mRNA-LNP, for safety and its ability to induce an immune response.
The trial will enroll up to 50 healthy volunteers aged ...
UArizona Health Sciences researchers unlocking new answers in the quest for safer, more effective opioid therapy
2023-05-15
TUCSON, Arizona — University of Arizona Health Sciences researchers are taking the foot off the brake in their quest to improve opioid therapy while decreasing its side effects.
Led by John Streicher, PhD, a Department of Pharmacology associate professor in the UArizona College of Medicine – Tucson and a member of the UArizona Health Sciences Comprehensive Pain and Addiction Center, the researchers have expanded upon their previous research focused on one specific protein – heat shock protein 90 – and its role in opioid receptor activation and pain relief. Their prior investigations have ...
Dr. Laura Moyer elected as Fellow of ASM International
2023-05-15
Dr. Laura Moyer ’99 ’02G ’05 PhD, manager of metallography, light optical microscopy, and X-ray diffraction at Lehigh University, has been elected as a Fellow of ASM International, the leading association of engineers and scientists in the field of materials science.
The honor recognizes Moyer’s “outstanding leadership and technical contributions to the education of personnel in both manufacturing and academia,” benefitting the field of materials science and engineering. The ...
Researchers design smaller, lighter space-based imaging spectrometers with high spectral resolution
2023-05-15
Researchers have developed a new smaller, lighter design for space-based imaging spectrometers with high spectral resolution. These high-dispersion imaging spectrometers could be used onboard spacecraft or satellites to study the Earth’s atmosphere or the atmospheres of other planets.
James P. McGuire, Jr. from NASA’s Jet Propulsion Laboratory in Southern California will present the new research at the Optica Design and Fabrication Conference, which will take place 04 – 08 June 2023 in Quebec City, Canada.
“This spectrometer provides the same measurement capabilities as conventional designs, but at one tenth the ...